A Senate bill intended to grant FDA greater regulatory power over the cosmetic industry is likely to see movement before the end of the year, congressional aides told Inside Health Policy . But a competing House bill is unlikely to move forward. Sens. Dianne Feinstein (D-CA) and Susan Collins (R-ME) received positive feedback from the Senate health committee on their bill, the Personal Care Products Safety Act, and hope for a hearing in September, a Feinstein aide told Inside Health...